BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36759392)

  • 1. Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.
    Moksud N; Wagner M; Pawełczyk K; Porębska I; Muszczyńska-Bernhard B; Kowal A; Wiśniewski A; Kosacka M; Kończak J; Karpiński P; Frydryk D; Andrzejczak A; Karabon L; Kuśnierczyk P; Jasek M
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6381-6390. PubMed ID: 36759392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women.
    Karami S; Sattarifard H; Kiumarsi M; Sarabandi S; Taheri M; Hashemi M; Bahari G; Ghavami S
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):3115-3123. PubMed ID: 33112575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
    Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
    Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the PD-L1 gene 3'-untranslated region are associated with the expression of PD-L1 in non-small cell lung cancer.
    Ohhara Y; Tomaru U; Kinoshita I; Hatanaka KC; Noguchi T; Hatanaka Y; Amono T; Matsuno Y; Dosaka-Akita H
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23216. PubMed ID: 38169142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.
    Kasamatsu T; Awata M; Ishihara R; Murakami Y; Gotoh N; Matsumoto M; Sawamura M; Yokohama A; Handa H; Tsukamoto N; Saitoh T; Murakami H
    Clin Exp Med; 2020 Feb; 20(1):51-62. PubMed ID: 31620907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility.
    Sakran MI; Alalawy AI; Alharbi AA; El-Hefnawy ME; Alzahrani SM; Alfuraydi A; Alzuaibr FM; Zidan NS; Elsaid AM; Toraih EA; Elshazli RM
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111180. PubMed ID: 37939515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant SNPs at the microRNA complementary site in the B7‑H1 3'‑untranslated region increase the risk of non‑small cell lung cancer.
    Du W; Zhu J; Chen Y; Zeng Y; Shen D; Zhang N; Ning W; Liu Z; Huang JA
    Mol Med Rep; 2017 Sep; 16(3):2682-2690. PubMed ID: 28677815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma.
    Koh YW; Han JH; Haam S; Lee HW
    Anticancer Res; 2024 May; 44(5):2081-2089. PubMed ID: 38677736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of PD-1 and PD-L1 gene polymorphisms with cancer risk: a meta-analysis based on 50 studies.
    Yang M; Liu Y; Zheng S; Geng P; He T; Lu L; Feng Y; Jiang Q
    Aging (Albany NY); 2024 Mar; 16(7):6068-6097. PubMed ID: 38546391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of PD-L1 mainly occurs in non-small cell lung cancer patients with squamous cell carcinoma or poor differentiation.
    Liu LU; Xie B; Zhu W; He Q; Zhou J; Liu S; Tao Y; Xiao D
    Oncol Res; 2023; 31(3):275-286. PubMed ID: 37305382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on the relationship between endoplasmic reticulum aminopeptidase2 genetic polymorphisms and non-small cell lung cancer in Yunnan Han population].
    Zhou J; Ma Q; Guo C; Shi L; Yao Y; Yu J; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):909-14. PubMed ID: 25609128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.
    Nomizo T; Ozasa H; Tsuji T; Funazo T; Yasuda Y; Yoshida H; Yagi Y; Sakamori Y; Nagai H; Hirai T; Kim YH
    Sci Rep; 2017 Mar; 7():45124. PubMed ID: 28332580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer.
    Larsen TV; Hussmann D; Nielsen AL
    Cancer Commun (Lond); 2019 Jun; 39(1):30. PubMed ID: 31159869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of PD-1 and PDL-1 gene polymorphisms with colorectal cancer risk and prognosis.
    Cevik M; Namal E; Iner-Koksal U; Dinc-Sener N; Karaalp A; Ciftci C; Susleyici B
    Mol Biol Rep; 2022 Mar; 49(3):1827-1836. PubMed ID: 35076848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma.
    Zhou RM; Li Y; Wang N; Huang X; Cao SR; Shan BE
    Cancer Genet; 2016 Sep; 209(9):365-375. PubMed ID: 27751353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.
    Al-Motassem Y; Shomaf M; Said I; Berger S; Ababneh N; Diab O; Obeidat N; Awidi A
    Asian Pac J Cancer Prev; 2015; 16(8):3101-9. PubMed ID: 25921104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
    Yin D; Zhang Y; Li H; Cheng L
    Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome.
    Han R; Gong X; Zhu Y; Liu X; Xia Y; Huang Y; Zhang M; Zhang Y; La X; Ding J
    Biomed Res Int; 2021; 2021():9596358. PubMed ID: 33521133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of genetic variation of programmed death-ligand 1 (PD-L1) on the prognosis of patients with non-small cell lung cancer who received platinum-based adjuvant chemotherapy].
    Zhang GW; Cheng RR; Zhang FR; Li P; Chu HY; Song XJ; Zhang GJ
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2682-2688. PubMed ID: 32921017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.